American Drug Delivery and Formulation Summit

Across two days, it brings together formulation and drug delivery experts to explore emerging approaches, share case studies and discuss strategies that can improve performance, manufacturability and patient outcomes. The programme is built for technical depth while still offering plenty of time for structured networking and peer-to-peer exchange.

Who the audience is and how many attend

Audience

• Formulation scientists and drug product development leaders
• Drug delivery and device/combination product specialists
• Biologics and complex modalities teams (including injectable and LNP/oligo delivery)
• Technical R&D leaders from pharma, biotech, and academia/government research organisations
• Solution providers supporting drug delivery, formulation, devices, analytics and development workflows

Scale

• Attendees: 300+
• Speakers: 36
• Companies represented: 140
• Sponsors: 29

What to expect

• Four parallel content streams: Small Molecules, Biologics, Tech & Innovation, and Devices & Combination Products
• A packed agenda of keynotes, case studies and panel discussions geared toward real-world R&D challenges
• Dedicated networking breaks, 1:1 meeting opportunities, and an evening drinks reception
• Strong interaction with industry solution providers, plus opportunities to share work via poster presentations/competitions